Ellen Rae Cooper, MD
Professor
Boston University School of Medicine
Dept of Pediatrics
Infectious Diseases

MD, University of Cincinnati College of Medicine
MA, Johns Hopkins University



Active Staff Hospital Privileges
Boston Medical Center
Pediatrics




A Phase 2/3, open-label, multicenter, multi-cohort, 2-part study evaluating pharmacokinetics (PK), safety, and efficacy of once-daily cobicistat-boosted darunavir (DRV/co) administered with a backgrou
02/10/2014 - 02/03/2016 (PI)
Gilead Sciences, Inc.


A Phase 2/3 Multicenter, Open-label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (BR)
02/04/2014 - 01/31/2016 (PI)
Gilead Sciences, Inc.


A phase 2/3 open-label study of pharmacokinetics, safety and antiviral activity of the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxii fumarte single table regimen (STR) in HIV-1 infected a
10/01/2012 - 09/30/2014 (PI)
Gilead Sciences, Inc.


An open label prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir, Tamiflu, in the treatment of children 1 to 12 years of age with confirmed influenza
04/30/2010 - 09/30/2013 (PI)
Roche Pharmaceuticals


An open label prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu) in the treatment of infants less than one year of age with influenza infecti
08/01/2010 - 08/15/2013 (PI)
F. Hoffmann-La Roche, Ltd.


A Pivotal Phase 3 Study of MEDI-524 (Numax), an Enhanced Potency Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children
09/14/2004 - 12/31/2009 (PI)
MedImmune, Inc.


A Prospective, Non-Interventional Study to Evaluate the Incidence of Hospitalizations and Medically-Attended Lower Respiratory Tract Infection (MALRI) in Premature Infants 32 to 35 Weeks Gestational Age Who are Not Recommended to Receive Prophylaxis for R
12/22/2006 - 06/30/2007 (PI)
MedImmune, Inc.

RSV Outbreaks in the Boston Medical Center NICU: The Role of Palibizumab in Prevention
10/01/2002 - 09/30/2003 (PI)
MedImmune, Inc.


An Epidemiologic Study of Pregnant Women and Their Newborn Infants to Describe Immune Status…
10/12/2015 - 03/31/2018 (PI)
Pfizer, Inc Pfizer, Inc

The SENTINEL 1 Study
12/02/2014 - 04/30/2017 (PI)
Astrazeneca Pharmaceuticals

Conducting CASG 117 - A Pharmacokinetic / Pharmcodynamic and Safety Evaluation of Investigational In
03/01/2010 - 09/30/2013 (PI)
Social & Scientific Systems Inc. NIH-NIAID

Combination Antiviral Focus Group
11/01/2009 - 09/30/2013 (PI)
Social & Scientific Systems Inc. NIH-NIAID

AIDSTAR - One Program
08/01/2010 - 12/31/2012 (PI)
John Snow, Inc. USAID

Title IV Case findings Early Intervention
10/01/2001 - 08/31/2012 (PI)
Justice Resource Institute DHHS

MassCARE (Community AIDS Resource Enhancement)
10/01/2001 - 06/30/2011 (PI)
DPH HRSA

Ethiopia Project - ICAP
02/23/2006 - 02/22/2011 (PI)
Columbia University CDC

Implications of Sleep and Fatigue in Pediatric HIV
08/01/2007 - 08/31/2009 (PI)
SUNY Stony Brook NIH

Maternal-to-Child Transmission (MTCT) Plus Initiative
05/01/2003 - 03/31/2009 (PI)
Columbia University CDC

Showing 10 of 19 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. Pediatr Infect Dis J. 2017 Jan; 36(1):61-62.View Related Profiles. PMID: 27749654.
  2. Peluso AM, Harnish BA, Miller NS, Cooper ER, Fujii AM. Effect of young sibling visitation on respiratory syncytial virus activity in a NICU. J Perinatol. 2015 Aug; 35(8):627-30.View Related Profiles. PMID: 25836315; DOI: 10.1038/jp.2015.27;.
  3. Clarke DF, Moloney C, Cooper ER. Iatrogenic Cushing's Syndrome due to pharmacokinetic interaction of intra-ocular corticosteroids and lopinavir/ritonavir in an HIV- infected adolescent: A case report. J AIDS Clin. Res. 2014.
  4. Lipshultz SE, Shearer WT, Thompson B, Rich KC, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein JS, O'Brien S, Cooper ER, Wilkinson JD, Miller TL, Colan SD. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol. 2011 Jan 4; 57(1):76-85. PMID: 21185505; PMCID: PMC3243620; DOI: 10.1016/j.jacc.2010.08.620;.
  5. Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, Radley DR, Esser MT, Weinberg A. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):197-204. PMID: 20574412; PMCID: PMC3033215; DOI: 10.1097/QAI.0b013e3181de8d26;.
  6. Comeau AM, Hale JE, Pai SY, Bonilla FA, Notarangelo LD, Pasternack MS, Meissner HC, Cooper ER, DeMaria A, Sahai I, Eaton RB. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency. J Inherit Metab Dis. 2010 Oct; 33(Suppl 2):S273-81. PMID: 20490925; DOI: 10.1007/s10545-010-9103-9;.
  7. Brogly SB, Foca M, Deville JG, Mirochnick M, Scott GB, Mofenson LM, Read JS, Viani RM, Burchett SK, Cooper ER, Browning R, Shapiro DE. Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):154-7.View Related Profiles. PMID: 20035168; PMCID: PMC3241607; DOI: 10.1097/QAI.0b013e3181b3adc2;.
  8. Weinberg A, Huang S, Fenton T, Patterson-Bartlett J, Gona P, Read JS, Dankner WM, Nachman S. Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment. J Acquir Immune Defic Syndr. 2009 Sep 1; 52(1):17-24. PMID: 19617848; PMCID: PMC2836885; DOI: 10.1097/QAI.0b013e3181b011f6;.
  9. Kankasa C, Carter RJ, Briggs N, Bulterys M, Chama E, Cooper ER, Costa C, Spielman E, Katepa-Bwalya M, M'soka T, Ou CY, Abrams EJ. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune Defic Syndr. 2009 Jun 1; 51(2):202-8. PMID: 19504732.
  10. Chantry CJ, Frederick MM, Meyer WA, Handelsman E, Rich K, Paul ME, Diaz C, Cooper ER, Foca M, Adeniyi-Jones SK, Moye J. Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2007 Jan; 26(1):53-60. PMID: 17195707.
Showing 10 of 32 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 32 publications over 21 distinct years, with a maximum of 3 publications in 2000 and 2001 and 2010

YearPublications
19881
19902
19911
19931
19941
19951
19962
19982
19992
20003
20013
20021
20051
20061
20071
20092
20103
20111
20141
20151
20171

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
Contact for Mentoring:


670 Albany St Biosquare III
Boston MA 02118
Google Map


Cooper's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department